Logo-bma
Biomed adv. 2025;2(2): 52-60. doi: 10.34172/bma.20

Systematic Review

Cell-free DNA as a diagnostic method in patients with neuroblastoma: A systematic review

Mehdi Mohebalizadeh 1 ORCID, Tooba Mohammadi 1, Somayeh Abolhasani 1,2, Zahra Asadi 1, Maryam Kahyaei-Aghdam 1, Negin Mahboubi 1, Rahim Asghari 3,4, Vahid Shafiei-Irannejad 5 * ORCID, Shahriar Alipour 5,6 * ORCID

Cited by CrossRef: 0


Acceptance Rate: 35%
Submission to First Decision: 20 Days
Received to Acceptance: 60 Days
Acceptance to Publication: 40 Days
*Average article statistics from the last 12 months of data.

In collaboration with